How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View

Background and objective: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA-PET/CT) and new treatment modalities have expanded the possibilities for diagnosing and managing metastatic prostate cancer, but have also raised questions about their implementation i...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniela E. Oprea-Lager, Tessa van Elst, Shafak Aluwini, Els Dewulf, Henk van der Poel, Herman Stoevelaar, Chris H. Bangma, Aart Beeker, Steve Boudewijns, Tom Budiharto, Igle-Jan de Jong, Kim C. de Vries, Maarten L. Donswijk, Jurgen J. Fütterer, Paul Hamberg, Linda Heijmen, Robert J. Hoekstra, Thomas M.A. Kerkhofs, Jules Lavalaye, Daphne Luijendijk-de Bruin, Walter Noordzij, Irma M. Oving, Debbie G.J. Robbrecht, Eva E. Schaake, Addy C.M. van de Luijtgaarden, Roderick C.N. van den Bergh, Franchette van den Berkmortel, Tom van der Hulle, Johannes C.K. van der Mijn, Joyce M. van Dodewaard-de Jong, Michel van Kruchten, Pim J. van Leeuwen, Evert van Limbergen, R.Jeroen A. van Moorselaar, Inge M. van Oort, Joep G.H. van Roermund, Robert J. van Soest, Theo Veninga, André N. Vis, Jens Voortman, Peter-Paul M. Willemse, Derya Yakar, Niven Mehra
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:European Urology Open Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S266616832500093X
Tags: Add Tag
No Tags, Be the first to tag this record!